Direct-acting antiviral (DAA) drugs have transformed the treatment of hepatitis C virus (HCV) infection. With cure rates above 95% and minimal side effects, DAAs are far more efficacious and safer than previously used therapies and have quickly become the standard of care for HCV. Public and…